Evidence map›Paper›PMID 20179761›Full record

ArticlePloS one2010

A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells.

Carina Banning, Jörg Votteler, Dirk Hoffmann, Herwig Koppensteiner, Martin Warmer, Rudolph Reimer, Frank Kirchhoff, Ulrich Schubert, Joachim Hauber, Michael Schindler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 164 citations in OpenAlex.

  1. ThebioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Carina BanningHeinrich-Pette-Institute for Experimental Virology and Immunology, Hamburg, Germany.
Jörg Votteler
Dirk Hoffmann
Herwig Koppensteiner
Martin Warmer
Rudolph Reimer
Frank Kirchhoff
Ulrich Schubert
Joachim Hauber
Michael Schindler
Leibniz Institute of Virology (LIV) · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversität Ulm · DE

Funding

Role of specific Nef functions in AIDS pathogenesisR01AI067057 · NIAID · UNIVERSITY OF ULM · PI KIRCHHOFF, FRANK · 2006 to 2008
$558k
NIAID NIH HHS R01 AI067057
6 · The paper itself

Abstract

backgroundFörsters resonance energy transfer (FRET) microscopy is widely used for the analysis of protein interactions in intact cells. However, FRET microscopy is technically challenging and does not allow assessing interactions in large cell numbers. To overcome these limitations we developed a flow cytometry-based FRET assay and analysed interactions of human and simian immunodeficiency virus (HIV and SIV) Nef and Vpu proteins with cellular factors, as well as HIV Rev multimer-formation.

resultsAmongst others, we characterize the interaction of Vpu with CD317 (also termed Bst-2 or tetherin), a host restriction factor that inhibits HIV release from infected cells and demonstrate that the direct binding of both is mediated by the Vpu membrane-spanning region. Furthermore, we adapted our assay to allow the identification of novel protein interaction partners in a high-throughput format.

conclusionThe presented combination of FRET and FACS offers the precious possibility to discover and define protein interactions in living cells and is expected to contribute to the identification of novel therapeutic targets for treatment of human diseases.

Indexed as

AnimalsAntigens, CDBinding SitesBone Marrow Stromal Antigen 2Cell LineFlow CytometryFluorescence Resonance Energy TransferGene Products, nefGPI-Linked ProteinsHeLa CellsHIV-1Human Immunodeficiency Virus ProteinsHumansImmunoprecipitationJurkat CellsLuminescent ProteinsAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, humanGene Products, nefGPI-Linked ProteinsHuman Immunodeficiency Virus ProteinsLuminescent ProteinsMembrane GlycoproteinsRecombinant Fusion ProteinsViral ProteinsViral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1

Identifiers

PMID20179761
PMCPMC2825263
OpenAlexW2040850920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.